U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07623044) titled 'Effects of Short-term Perioperative Daidzein Intervention on Liver Histopathology in Patients With MASLD' on May 21.
Brief Summary: This clinical trial aims to learn whether daidzein can improve liver tissue changes in adults with metabolic dysfunction-associated steatotic liver disease, also called MASLD. MASLD is a liver condition linked to extra fat in the liver and metabolic problems such as obesity, diabetes, abnormal blood lipids, or high blood pressure.
Daidzein is a natural compound found in soy. Earlier laboratory studies suggest that daidzein may help protect the liver. This study will test whether taking daidzein for a sh...